Please check your internet connection and try again.
## Ecospirin (Aspirin, Enteric-Coated)
### Overview
Ecospirin is an enteric-coated formulation of aspirin, a nonsteroidal anti-inflammatory drug (NSAID) with analgesic, antipyretic, and antiplatelet properties. Enteric coating is designed to delay absorption until the drug reaches the small intestine, potentially reducing gastric irritation.
### Primary Indications
* **Cardiovascular Prophylaxis:** Prevention of myocardial infarction (MI) and stroke in patients with established cardiovascular disease or risk factors.
* **Secondary Prevention:** Following an acute coronary syndrome (ACS) or ischemic stroke/transient ischemic attack (TIA).
* **Pain and Inflammation:** Relief of mild to moderate pain and reduction of fever (less common use for this specific formulation due to delayed absorption).
### Adult Dosing
* **Cardiovascular Prophylaxis/Secondary Prevention:**
* Commonly: 75 mg to 100 mg once daily.
* Higher doses (e.g., 325 mg once daily) may be used in specific situations, such as post-acute coronary syndrome or percutaneous coronary intervention (PCI), often in combination with other antiplatelets. Dosing depends on local protocols and clinical indication.
* **Pain/Inflammation:** Not typically the preferred formulation due to delayed onset of action. If used, standard adult aspirin doses (e.g., 325-650 mg every 4-6 hours) would apply, but the enteric coating may alter the expected efficacy timeline. Maximum daily dose generally should not exceed 4000 mg, but lower doses are used for antiplatelet effects.
### Pediatric Dosing
Aspirin is generally **contraindicated** in children and teenagers with viral infections (e.g., influenza, chickenpox) due to the risk of Reye's syndrome. If aspirin is deemed absolutely necessary for a specific pediatric indication (e.g., Kawasaki disease), dosing is highly individualized and should be managed by a specialist. Typical doses for Kawasaki disease are around 30-100 mg/kg/day divided into multiple doses.
### Dose Adjustments
* **Renal Impairment:** No specific dose adjustment typically needed for low-dose aspirin (cardiovascular prophylaxis). Higher doses may require caution and monitoring in severe renal impairment.
* **Hepatic Impairment:** Use with caution. Aspirin can exacerbate liver disease.
* **Elderly:** Increased risk of gastrointestinal bleeding and other adverse effects. Lower doses and caution are recommended.
### Contraindications
* Known hypersensitivity to aspirin, salicylates, NSAIDs, or any component of the formulation.
* Active gastrointestinal bleeding or peptic ulcer disease.
* Children and teenagers with viral infections.
* Severe hepatic impairment.
* Severe renal impairment.
* Certain bleeding disorders (e.g., hemophilia).
* Third trimester of pregnancy.
### Adverse Effects
* **Common:** Dyspepsia, heartburn, nausea, abdominal pain.
* **Serious:** Gastrointestinal bleeding, peptic ulceration, tinnitus (especially at higher doses), bronchospasm (in aspirin-sensitive asthma), increased bleeding risk, Reye's syndrome (in children/teenagers with viral illness), hypersensitivity reactions.
### Key Drug Interactions
* **Anticoagulants (e.g., warfarin, DOACs):** Significantly increased risk of bleeding.
* **Other Antiplatelets (e.g., clopidogrel, ticagrelor):** Increased risk of bleeding.
* **NSAIDs:** Additive gastrointestinal toxicity and increased bleeding risk.
* **Corticosteroids:** Increased risk of gastrointestinal ulceration.
* **Alcohol:** Increased risk of gastrointestinal bleeding.
* **Methotrexate:** Aspirin can increase methotrexate toxicity.
* **Uricosuric agents (e.g., probenecid):** Aspirin can interfere with their uricosuric effect.
### Monitoring
* **Signs and symptoms of gastrointestinal bleeding:** Melena, hematemesis, abdominal pain.
* **Signs and symptoms of bleeding:** Bruising, prolonged bleeding from cuts, epistaxis.
* **Renal function:** Especially in patients with risk factors for renal impairment or on higher doses.
* **Auditory function:** Tinnitus can be an early sign of salicylate toxicity.
### Clinical Pearls
* The enteric coating delays absorption, so onset of analgesic/antipyretic effects may be slower compared to non-enteric coated aspirin. This formulation is primarily chosen for its gastroprotective benefits when long-term, low-dose aspirin therapy is indicated.
* Taking with food or milk may help minimize gastric upset, although the enteric coating is designed to mitigate this.
* Patients should be advised to avoid concurrent use of other NSAIDs without consulting a healthcare provider.
* Discontinue aspirin at least 5-7 days prior to elective surgery, if possible, due to its irreversible antiplatelet effect.
***
**Disclaimer:** This information is intended for healthcare professionals and does not replace comprehensive drug information resources. Always consult the most current prescribing information and institutional protocols before making clinical decisions. Dosing and indications can vary based on specific circumstances and patient populations.
